Kure Cells
PrivateLast Round
Series A
Oct 23, 2025
Est. Valuation
$106.15M
Total Funding Raised
$10.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kure Cells operates in Healthcare & Life Sciences and is based in Shaker Heights, Ohio. Its latest recorded funding round was a Series A round in October 2025.
Kure Cells is a biotechnology company developing a proprietary Ultra-Fast (UF) CAR-T platform that manufactures cell therapies in less than 24 hours to treat various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kure Cells Comparables
Compare Kure Cells with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AstraZeneca | 75% | |
| Ori Biotech | 74% | |
| Galapagos NV | 72% |
For institutional investors. Book with your work email.
Kure Cells Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 23, 2025 | ||||
| Grant | Sep 19, 2024 |
For institutional investors. Book with your work email.
Kure Cells Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Wa'ed Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
Monthly visitors grew 101% MoM.
- Oct 23, 2025
Raised $10M led by Wa'ed Ventures
For institutional investors. Book with your work email.
Kure Cells Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kure Cells's valuation, stock price, and market status.
Is Kure Cells a public or private company?
Kure Cells is a private company.
What is the current stock price of Kure Cells?
Kure Cells is a private company, so its shares have no public market price. Caplight tracks Kure Cells's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kure Cells worth (valuation)?
Kure Cells's valuation is estimated at $106.2M based on funding round data.
Can I buy Kure Cells stock?
Kure Cells shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kure Cells's last funding round?
Kure Cells's most recent funding round was Series A on October 23, 2025.
Who are the main investors in Kure Cells?
Key investors in Kure Cells include Wa'ed Ventures.
Will Kure Cells IPO soon?
No public IPO plans have been announced for Kure Cells.
How can I track Kure Cells secondary market activity?
Caplight tracks bids, offers, and trades in Kure Cells's shares on secondary markets.